Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer

Vanderbilt-Ingram Cancer Center · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
metastaticbreastcancer
metastatic breast cancer, fgfr inhibitor, er+ metastatic breast cancer, cdk4/6 inhibitor, endocrine therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 890751
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.